Walk Test

Walk Test

A group of performance-based tests that measure the distance a patient walks in a defined time, e.g., 2 min, 6 min, and 12 min. Walk tests measure the functional level of patients suffering from a wide range of cardiac, respiratory, neurological, and musculoskeletal conditions.
References in periodicals archive ?
The primary endpoint of the study is change in distance walked during the six-minute walk test and secondary endpoints include additional functional assessments, patient-reported outcomes and safety.
Trends suggesting benefit, which did not reach statistical significance, were observed for the Timed Up and Go (TUG) and the 2 Minute Walk Test (2MWT).
Efficacy was primarily assessed via the six-minute walk test in ten patients who could perform the test.
This can greatly reduce the time, cost and quality of testing and validating performance over traditional walk test methods by emulating the actions of real clients in a repeatable and scaleable manner.
The six-minute walk test, the modified Medical Research Council Dyspnea Scale, body plethysmographs, carbon monoxide diffusion tests, and arterial blood gas analysis were practiced.
05) difference in BWS and NBWS for Dynamic Gait Index, Timed Get Up and Go Test, Timed 10 Meter Walk Test (Self-Selected Velocity), and Timed 10 Meter Walk Test (Fast-Velocity).
The six minute walk test (6MWT), Stroke Impact Scale (SIS) and the 10 metre walk test (10MWT) were used as secondary outcome measures.
6 times higher chances of cough and/or phlegm (Figure 2), and those with emphysema walked 35 meters (38 yards) less on the 6-minute walk test.
17, 2016--Results from a study sponsored by CardioCell LLC show statistically significant improvement in six-minute walk test, quality-of-life scores as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) and favorable immune modulatory benefits after injections of mesenchymal stem cells.
17, 2016 --Results from a study sponsored by CardioCell LLC show statistically significant improvement in six-minute walk test, quality-of-life scores as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) and favorable immune modulatory benefits after injections of mesenchymal stem cells.
The purpose of the study was to explore the influence of a 6-minute walk test (6MWT) as a simple, non-invasive tool to detect RV dysfunction in patients with DPLD.